中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [15]
生物物理研究所 [3]
合肥物质科学研究院 [3]
苏州纳米技术与纳米仿... [2]
数学与系统科学研究院 [2]
云南天文台 [2]
更多
采集方式
OAI收割 [32]
iSwitch采集 [1]
内容类型
期刊论文 [33]
发表日期
2025 [1]
2024 [2]
2023 [1]
2022 [1]
2021 [2]
2020 [1]
更多
学科主题
Immunology [2]
天文学 [2]
Gastroente... [1]
筛选
浏览/检索结果:
共33条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Design, Synthesis, and Pharmacological Evaluation of Quinazoline and Quinoline Derivatives as Potent ENPP1 Inhibitors for Cancer Immunotherapy
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 页码: 18
作者:
He, Jie
;
Ma, Xiaoyu
;
Sun, Jia
;
Chen, Manman
;
Xu, Lan
  |  
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2025/04/01
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2024, 卷号: 15
作者:
Jiang, Jiahui
;
Liu, Yunhe
;
Qin, Jiangjiang
;
Chen, Jianfeng
;
Wu, Jingjing
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2024/11/20
Discovery of Pyrido[2,3-
d
]pyrimidin-7-one Derivatives as Highly Potent and Efficacious Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Cancer Treatment
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 5, 页码: 3986-4006
作者:
Sun, Yaoliang
;
Chen, Manman
;
Han, Yuyan
;
Li, Weiqiang
;
Ma, Xiaoyu
  |  
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2024/05/07
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors
期刊论文
OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 153
作者:
Zhang, Xu
;
Wang, Yuxiang
;
Zhang, Xi
;
Shen, Yanyan
;
Yang, Kang
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2024/03/27
SAF-248,a novel PI3Kδ-selective inhibitor,potently suppresses the growth of diffuse large B-cell lymphoma
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 卷号: 43, 期号: 1, 页码: 209
作者:
Zhang Xi
;
Duan Yuting
;
Wang Yi
;
Zhao Xingdong
;
Sun Yiming
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2023/05/22
PI3K6
PI3K/AKT/mTOR
diffuse large B-cell lymphoma
resistance
combination therapy
PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma
期刊论文
OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 卷号: 6, 期号: 1, 页码: 3
作者:
Xie, Qin
;
Chi, Shuaishuai
;
Fang, Yanfen
;
Sun, Yiming
;
Meng, Linghua
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2021/05/24
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2021, 卷号: 12
作者:
Hu, Xin
;
Estecio, Marcos R.
;
Chen, Runzhe
;
Reuben, Alexandre
;
Wang, Linghua
  |  
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2021/09/06
N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors.
期刊论文
OAI收割
CANCER IMMUNOLOGY RESEARCH, 2020, 卷号: 8, 期号: 3, 页码: 51-51
作者:
Chen, Shulun
;
Guo, Wei
;
Sun, Pu
;
Meng, Linghua
;
Zhang, Ao
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/07/01
Design, synthesis and antitumor study of a series of N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 179, 页码: 38-55
作者:
Chen, Shulun
;
Guo, Wei
;
Liu, Xiaohua
;
Sun, Pu
;
Wang, Yi
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2020/07/01
Indoleamine 2,3-dioxygenase
Immunotherapy
Oxadiazole
PD-1
Life span
Simultaneous inhibition of PI3K alpha and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
期刊论文
OAI收割
CANCER BIOLOGY & MEDICINE, 2019, 卷号: 16, 期号: 1, 页码: 66-+
作者:
Wang, Yuxiang
;
Li, Xian
;
Liu, Xueling
;
Chen, Yi
;
Yang, Chunhao
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2020/07/01
PI3K alpha
CDK4/6
KRAS
NSCLC
CYH33